nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2D6—breast cancer	0.117	0.538	CbGaD
Mianserin—CYP3A4—breast cancer	0.101	0.462	CbGaD
Mianserin—HTR6—Raloxifene—breast cancer	0.0636	0.139	CbGbCtD
Mianserin—HTR2B—Raloxifene—breast cancer	0.0568	0.125	CbGbCtD
Mianserin—CYP2B6—Thiotepa—breast cancer	0.0344	0.0754	CbGbCtD
Mianserin—CYP1A2—Anastrozole—breast cancer	0.0266	0.0584	CbGbCtD
Mianserin—CYP1A2—Toremifene—breast cancer	0.0243	0.0534	CbGbCtD
Mianserin—CYP2B6—Raloxifene—breast cancer	0.0229	0.0503	CbGbCtD
Mianserin—CYP3A4—Exemestane—breast cancer	0.0184	0.0403	CbGbCtD
Mianserin—CYP2D6—Idarubicin—breast cancer	0.0166	0.0364	CbGbCtD
Mianserin—CYP3A4—Letrozole—breast cancer	0.0156	0.0343	CbGbCtD
Mianserin—CYP2B6—Tamoxifen—breast cancer	0.0152	0.0333	CbGbCtD
Mianserin—CYP3A4—Anastrozole—breast cancer	0.0139	0.0306	CbGbCtD
Mianserin—CYP3A4—Toremifene—breast cancer	0.0127	0.028	CbGbCtD
Mianserin—CYP3A4—Fulvestrant—breast cancer	0.0119	0.026	CbGbCtD
Mianserin—CYP2B6—Irinotecan—breast cancer	0.0116	0.0255	CbGbCtD
Mianserin—CYP3A4—Thiotepa—breast cancer	0.0106	0.0232	CbGbCtD
Mianserin—CYP3A4—Ixabepilone—breast cancer	0.00966	0.0212	CbGbCtD
Mianserin—CYP3A4—Lapatinib—breast cancer	0.0093	0.0204	CbGbCtD
Mianserin—CYP1A2—Tamoxifen—breast cancer	0.00889	0.0195	CbGbCtD
Mianserin—CYP2D6—Vinorelbine—breast cancer	0.00811	0.0178	CbGbCtD
Mianserin—CYP2D6—Tamoxifen—breast cancer	0.00732	0.0161	CbGbCtD
Mianserin—CYP3A4—Raloxifene—breast cancer	0.00705	0.0155	CbGbCtD
Mianserin—CYP1A2—Fluorouracil—breast cancer	0.00655	0.0144	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—breast cancer	0.00636	0.014	CbGbCtD
Mianserin—CYP3A4—Vinorelbine—breast cancer	0.00516	0.0113	CbGbCtD
Mianserin—CYP2D6—Vinblastine—breast cancer	0.005	0.011	CbGbCtD
Mianserin—CYP3A4—Tamoxifen—breast cancer	0.00466	0.0102	CbGbCtD
Mianserin—CYP3A4—Mitoxantrone—breast cancer	0.00454	0.00996	CbGbCtD
Mianserin—CYP3A4—Paclitaxel—breast cancer	0.00362	0.00795	CbGbCtD
Mianserin—CYP3A4—Irinotecan—breast cancer	0.00358	0.00784	CbGbCtD
Mianserin—CYP3A4—Vinblastine—breast cancer	0.00318	0.00697	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—breast cancer	0.00307	0.00674	CbGbCtD
Mianserin—CYP3A4—Docetaxel—breast cancer	0.00262	0.00575	CbGbCtD
Mianserin—CYP3A4—Doxorubicin—breast cancer	0.00195	0.00429	CbGbCtD
Mianserin—HRH4—bone marrow—breast cancer	0.0011	0.0596	CbGeAlD
Mianserin—HRH2—skin of body—breast cancer	0.000629	0.0339	CbGeAlD
Mianserin—OPRK1—female reproductive system—breast cancer	0.000498	0.0268	CbGeAlD
Mianserin—HRH2—adrenal gland—breast cancer	0.000479	0.0259	CbGeAlD
Mianserin—ADRA2C—nipple—breast cancer	0.000459	0.0248	CbGeAlD
Mianserin—HRH2—endocrine gland—breast cancer	0.000416	0.0224	CbGeAlD
Mianserin—CYP1A2—nipple—breast cancer	0.000398	0.0215	CbGeAlD
Mianserin—HTR2B—skin of body—breast cancer	0.000373	0.0201	CbGeAlD
Mianserin—HRH1—nipple—breast cancer	0.000373	0.0201	CbGeAlD
Mianserin—ADRA2A—nipple—breast cancer	0.000366	0.0198	CbGeAlD
Mianserin—HTR2B—endometrium—breast cancer	0.000352	0.019	CbGeAlD
Mianserin—HTR7—epithelium—breast cancer	0.000336	0.0181	CbGeAlD
Mianserin—HTR2B—uterus—breast cancer	0.000324	0.0175	CbGeAlD
Mianserin—HTR2B—adipose tissue—breast cancer	0.000317	0.0171	CbGeAlD
Mianserin—HTR1D—female reproductive system—breast cancer	0.000314	0.0169	CbGeAlD
Mianserin—HTR2C—female reproductive system—breast cancer	0.00031	0.0167	CbGeAlD
Mianserin—SLC6A4—female reproductive system—breast cancer	0.000294	0.0159	CbGeAlD
Mianserin—HTR2B—female reproductive system—breast cancer	0.000292	0.0157	CbGeAlD
Mianserin—HRH2—lymph node—breast cancer	0.000287	0.0155	CbGeAlD
Mianserin—HTR2B—adrenal gland—breast cancer	0.000285	0.0154	CbGeAlD
Mianserin—ADRA2C—endometrium—breast cancer	0.000277	0.0149	CbGeAlD
Mianserin—SLC6A2—female reproductive system—breast cancer	0.000259	0.014	CbGeAlD
Mianserin—DRD2—pituitary gland—breast cancer	0.000258	0.0139	CbGeAlD
Mianserin—HTR2A—embryo—breast cancer	0.000257	0.0139	CbGeAlD
Mianserin—ADRA2C—uterus—breast cancer	0.000255	0.0138	CbGeAlD
Mianserin—HTR1A—adrenal gland—breast cancer	0.000255	0.0138	CbGeAlD
Mianserin—SLC6A2—adrenal gland—breast cancer	0.000253	0.0136	CbGeAlD
Mianserin—HRH1—epithelium—breast cancer	0.000251	0.0135	CbGeAlD
Mianserin—ADRA2C—pituitary gland—breast cancer	0.000251	0.0135	CbGeAlD
Mianserin—HTR7—female reproductive system—breast cancer	0.00025	0.0135	CbGeAlD
Mianserin—ADRA2C—adipose tissue—breast cancer	0.00025	0.0135	CbGeAlD
Mianserin—SLC6A4—endocrine gland—breast cancer	0.000249	0.0134	CbGeAlD
Mianserin—CYP2B6—skin of body—breast cancer	0.000244	0.0132	CbGeAlD
Mianserin—HTR7—adrenal gland—breast cancer	0.000244	0.0131	CbGeAlD
Mianserin—HRH1—endometrium—breast cancer	0.000225	0.0121	CbGeAlD
Mianserin—ADRA2C—adrenal gland—breast cancer	0.000224	0.0121	CbGeAlD
Mianserin—HTR1A—endocrine gland—breast cancer	0.000221	0.0119	CbGeAlD
Mianserin—ADRA2A—endometrium—breast cancer	0.000221	0.0119	CbGeAlD
Mianserin—Azatadine—CYP3A4—breast cancer	0.000221	0.0898	CrCbGaD
Mianserin—SLC6A2—endocrine gland—breast cancer	0.000219	0.0118	CbGeAlD
Mianserin—HTR7—endocrine gland—breast cancer	0.000211	0.0114	CbGeAlD
Mianserin—HTR2A—epithelium—breast cancer	0.00021	0.0113	CbGeAlD
Mianserin—ADRA2C—female gonad—breast cancer	0.000209	0.0113	CbGeAlD
Mianserin—ADRA2A—uterus—breast cancer	0.000204	0.011	CbGeAlD
Mianserin—HRH1—adipose tissue—breast cancer	0.000203	0.0109	CbGeAlD
Mianserin—ADRA2A—pituitary gland—breast cancer	0.0002	0.0108	CbGeAlD
Mianserin—DRD2—endocrine gland—breast cancer	0.0002	0.0108	CbGeAlD
Mianserin—ADRA2A—adipose tissue—breast cancer	0.000199	0.0107	CbGeAlD
Mianserin—CYP2B6—female reproductive system—breast cancer	0.000191	0.0103	CbGeAlD
Mianserin—HRH1—female reproductive system—breast cancer	0.000186	0.0101	CbGeAlD
Mianserin—CYP2B6—adrenal gland—breast cancer	0.000186	0.0101	CbGeAlD
Mianserin—ADRA2A—female reproductive system—breast cancer	0.000183	0.00988	CbGeAlD
Mianserin—HRH1—adrenal gland—breast cancer	0.000182	0.00982	CbGeAlD
Mianserin—ADRA2A—adrenal gland—breast cancer	0.000179	0.00964	CbGeAlD
Mianserin—HTR2B—lymph node—breast cancer	0.000171	0.0092	CbGeAlD
Mianserin—HTR2A—pituitary gland—breast cancer	0.00017	0.00918	CbGeAlD
Mianserin—HRH1—female gonad—breast cancer	0.00017	0.00915	CbGeAlD
Mianserin—CYP1A2—endocrine gland—breast cancer	0.000169	0.00909	CbGeAlD
Mianserin—ADRA2A—female gonad—breast cancer	0.000167	0.00899	CbGeAlD
Mianserin—CYP2B6—endocrine gland—breast cancer	0.000162	0.00872	CbGeAlD
Mianserin—HRH1—endocrine gland—breast cancer	0.000158	0.00851	CbGeAlD
Mianserin—HTR2A—female reproductive system—breast cancer	0.000156	0.0084	CbGeAlD
Mianserin—ADRA2A—endocrine gland—breast cancer	0.000155	0.00836	CbGeAlD
Mianserin—HTR2A—adrenal gland—breast cancer	0.000152	0.0082	CbGeAlD
Mianserin—SLC6A2—lymph node—breast cancer	0.000152	0.00818	CbGeAlD
Mianserin—Epinastine—CYP2D6—breast cancer	0.000149	0.0606	CrCbGaD
Mianserin—CYP3A4—female reproductive system—breast cancer	0.000144	0.00778	CbGeAlD
Mianserin—CYP2D6—female reproductive system—breast cancer	0.000142	0.00765	CbGeAlD
Mianserin—Mequitazine—CYP2D6—breast cancer	0.00014	0.057	CrCbGaD
Mianserin—ADRA2C—lymph node—breast cancer	0.000134	0.00724	CbGeAlD
Mianserin—HTR2A—endocrine gland—breast cancer	0.000132	0.00711	CbGeAlD
Mianserin—CYP2D6—female gonad—breast cancer	0.000129	0.00696	CbGeAlD
Mianserin—Epinastine—CYP3A4—breast cancer	0.000128	0.052	CrCbGaD
Mianserin—CYP3A4—endocrine gland—breast cancer	0.000122	0.00658	CbGeAlD
Mianserin—Mequitazine—CYP3A4—breast cancer	0.00012	0.0489	CrCbGaD
Mianserin—CYP2D6—endocrine gland—breast cancer	0.00012	0.00648	CbGeAlD
Mianserin—Oxcarbazepine—CYP3A4—breast cancer	0.000118	0.0479	CrCbGaD
Mianserin—Mirtazapine—CYP2D6—breast cancer	0.000117	0.0477	CrCbGaD
Mianserin—Nortriptyline—PTGS1—breast cancer	0.000113	0.046	CrCbGaD
Mianserin—Feeling abnormal—Irinotecan—breast cancer	0.000111	0.000619	CcSEcCtD
Mianserin—Feeling abnormal—Mitoxantrone—breast cancer	0.000111	0.000619	CcSEcCtD
Mianserin—Confusional state—Paclitaxel—breast cancer	0.00011	0.000617	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—breast cancer	0.00011	0.000615	CcSEcCtD
Mianserin—Pruritus—Thiotepa—breast cancer	0.00011	0.000615	CcSEcCtD
Mianserin—Oedema—Paclitaxel—breast cancer	0.00011	0.000612	CcSEcCtD
Mianserin—HRH1—lymph node—breast cancer	0.000109	0.00588	CbGeAlD
Mianserin—Erectile dysfunction—Methotrexate—breast cancer	0.000108	0.000606	CcSEcCtD
Mianserin—Feeling abnormal—Gemcitabine—breast cancer	0.000108	0.000603	CcSEcCtD
Mianserin—Shock—Paclitaxel—breast cancer	0.000108	0.000602	CcSEcCtD
Mianserin—Dizziness—Vinorelbine—breast cancer	0.000108	0.000602	CcSEcCtD
Mianserin—Nervous system disorder—Paclitaxel—breast cancer	0.000107	0.0006	CcSEcCtD
Mianserin—Thrombocytopenia—Paclitaxel—breast cancer	0.000107	0.000599	CcSEcCtD
Mianserin—ADRA2A—lymph node—breast cancer	0.000107	0.00578	CbGeAlD
Mianserin—Tachycardia—Paclitaxel—breast cancer	0.000107	0.000598	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—breast cancer	0.000107	0.000595	CcSEcCtD
Mianserin—Skin disorder—Paclitaxel—breast cancer	0.000106	0.000595	CcSEcCtD
Mianserin—Epinastine—ABCB1—breast cancer	0.000106	0.0433	CrCbGaD
Mianserin—Feeling abnormal—Fluorouracil—breast cancer	0.000106	0.000592	CcSEcCtD
Mianserin—Anaemia—Docetaxel—breast cancer	0.000105	0.000588	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—breast cancer	0.000105	0.000586	CcSEcCtD
Mianserin—Pancytopenia—Epirubicin—breast cancer	0.000105	0.000585	CcSEcCtD
Mianserin—Tremor—Capecitabine—breast cancer	0.000103	0.000577	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—breast cancer	0.000103	0.000576	CcSEcCtD
Mianserin—Dizziness—Thiotepa—breast cancer	0.000103	0.000575	CcSEcCtD
Mianserin—Rash—Vinorelbine—breast cancer	0.000103	0.000574	CcSEcCtD
Mianserin—Oxcarbazepine—ALB—breast cancer	0.000103	0.0418	CrCbGaD
Mianserin—Dermatitis—Vinorelbine—breast cancer	0.000103	0.000573	CcSEcCtD
Mianserin—Hypotension—Paclitaxel—breast cancer	0.000102	0.000572	CcSEcCtD
Mianserin—Headache—Vinorelbine—breast cancer	0.000102	0.00057	CcSEcCtD
Mianserin—Syncope—Docetaxel—breast cancer	0.000102	0.00057	CcSEcCtD
Mianserin—Leukopenia—Docetaxel—breast cancer	0.000102	0.000569	CcSEcCtD
Mianserin—Anaemia—Capecitabine—breast cancer	0.000102	0.000569	CcSEcCtD
Mianserin—Mirtazapine—CYP3A4—breast cancer	0.000101	0.0409	CrCbGaD
Mianserin—Weight increased—Epirubicin—breast cancer	0.0001	0.00056	CcSEcCtD
Mianserin—Loss of consciousness—Docetaxel—breast cancer	0.0001	0.000559	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Paclitaxel—breast cancer	9.98e-05	0.000558	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—breast cancer	9.93e-05	0.000555	CcSEcCtD
Mianserin—Vertigo—Capecitabine—breast cancer	9.9e-05	0.000553	CcSEcCtD
Mianserin—Syncope—Capecitabine—breast cancer	9.88e-05	0.000552	CcSEcCtD
Mianserin—Leukopenia—Capecitabine—breast cancer	9.86e-05	0.000551	CcSEcCtD
Mianserin—Convulsion—Docetaxel—breast cancer	9.86e-05	0.000551	CcSEcCtD
Mianserin—Paraesthesia—Paclitaxel—breast cancer	9.84e-05	0.00055	CcSEcCtD
Mianserin—Hypertension—Docetaxel—breast cancer	9.83e-05	0.000549	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—breast cancer	9.82e-05	0.000549	CcSEcCtD
Mianserin—Rash—Thiotepa—breast cancer	9.81e-05	0.000548	CcSEcCtD
Mianserin—Dermatitis—Thiotepa—breast cancer	9.8e-05	0.000548	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—breast cancer	9.8e-05	0.000547	CcSEcCtD
Mianserin—Headache—Thiotepa—breast cancer	9.75e-05	0.000545	CcSEcCtD
Mianserin—Somnolence—Paclitaxel—breast cancer	9.74e-05	0.000544	CcSEcCtD
Mianserin—Arthralgia—Docetaxel—breast cancer	9.69e-05	0.000541	CcSEcCtD
Mianserin—Myalgia—Docetaxel—breast cancer	9.69e-05	0.000541	CcSEcCtD
Mianserin—Loss of consciousness—Capecitabine—breast cancer	9.68e-05	0.000541	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—breast cancer	9.68e-05	0.000541	CcSEcCtD
Mianserin—Asthenia—Irinotecan—breast cancer	9.64e-05	0.000539	CcSEcCtD
Mianserin—Asthenia—Mitoxantrone—breast cancer	9.64e-05	0.000539	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.62e-05	0.000538	CcSEcCtD
Mianserin—Jaundice—Epirubicin—breast cancer	9.57e-05	0.000535	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—breast cancer	9.53e-05	0.000533	CcSEcCtD
Mianserin—Prochlorperazine—CYP2D6—breast cancer	9.53e-05	0.0387	CrCbGaD
Mianserin—Hypertension—Capecitabine—breast cancer	9.51e-05	0.000531	CcSEcCtD
Mianserin—Dry mouth—Docetaxel—breast cancer	9.48e-05	0.000529	CcSEcCtD
Mianserin—Gastrointestinal disorder—Paclitaxel—breast cancer	9.46e-05	0.000529	CcSEcCtD
Mianserin—Fatigue—Paclitaxel—breast cancer	9.45e-05	0.000528	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—breast cancer	9.42e-05	0.000526	CcSEcCtD
Mianserin—Asthenia—Gemcitabine—breast cancer	9.39e-05	0.000525	CcSEcCtD
Mianserin—Myalgia—Capecitabine—breast cancer	9.38e-05	0.000524	CcSEcCtD
Mianserin—Arthralgia—Capecitabine—breast cancer	9.38e-05	0.000524	CcSEcCtD
Mianserin—Constipation—Paclitaxel—breast cancer	9.37e-05	0.000524	CcSEcCtD
Mianserin—Confusional state—Docetaxel—breast cancer	9.37e-05	0.000523	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.32e-05	0.00052	CcSEcCtD
Mianserin—Hepatobiliary disease—Epirubicin—breast cancer	9.29e-05	0.000519	CcSEcCtD
Mianserin—Oedema—Docetaxel—breast cancer	9.29e-05	0.000519	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—breast cancer	9.28e-05	0.000518	CcSEcCtD
Mianserin—Pruritus—Gemcitabine—breast cancer	9.26e-05	0.000517	CcSEcCtD
Mianserin—Dry mouth—Capecitabine—breast cancer	9.17e-05	0.000513	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—breast cancer	9.17e-05	0.000512	CcSEcCtD
Mianserin—Shock—Docetaxel—breast cancer	9.14e-05	0.000511	CcSEcCtD
Mianserin—Nervous system disorder—Docetaxel—breast cancer	9.11e-05	0.000509	CcSEcCtD
Mianserin—Pruritus—Fluorouracil—breast cancer	9.1e-05	0.000509	CcSEcCtD
Mianserin—Thrombocytopenia—Docetaxel—breast cancer	9.09e-05	0.000508	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—breast cancer	9.09e-05	0.000508	CcSEcCtD
Mianserin—Confusional state—Capecitabine—breast cancer	9.07e-05	0.000507	CcSEcCtD
Mianserin—Tachycardia—Docetaxel—breast cancer	9.06e-05	0.000506	CcSEcCtD
Mianserin—Feeling abnormal—Paclitaxel—breast cancer	9.03e-05	0.000504	CcSEcCtD
Mianserin—Skin disorder—Docetaxel—breast cancer	9.02e-05	0.000504	CcSEcCtD
Mianserin—Oedema—Capecitabine—breast cancer	8.99e-05	0.000502	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—breast cancer	8.98e-05	0.000502	CcSEcCtD
Mianserin—Dizziness—Irinotecan—breast cancer	8.88e-05	0.000496	CcSEcCtD
Mianserin—Jaundice—Doxorubicin—breast cancer	8.86e-05	0.000495	CcSEcCtD
Mianserin—Shock—Capecitabine—breast cancer	8.85e-05	0.000494	CcSEcCtD
Mianserin—Nervous system disorder—Capecitabine—breast cancer	8.82e-05	0.000493	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—breast cancer	8.82e-05	0.000493	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—breast cancer	8.81e-05	0.000492	CcSEcCtD
Mianserin—Thrombocytopenia—Capecitabine—breast cancer	8.8e-05	0.000492	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—breast cancer	8.79e-05	0.000491	CcSEcCtD
Mianserin—Tachycardia—Capecitabine—breast cancer	8.78e-05	0.00049	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—breast cancer	8.74e-05	0.000489	CcSEcCtD
Mianserin—Skin disorder—Capecitabine—breast cancer	8.73e-05	0.000488	CcSEcCtD
Mianserin—Hypotension—Docetaxel—breast cancer	8.68e-05	0.000485	CcSEcCtD
Mianserin—Connective tissue disorder—Epirubicin—breast cancer	8.67e-05	0.000484	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—breast cancer	8.6e-05	0.00048	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—breast cancer	8.55e-05	0.000478	CcSEcCtD
Mianserin—Dizziness—Fluorouracil—breast cancer	8.51e-05	0.000475	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—breast cancer	8.49e-05	0.000474	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—breast cancer	8.48e-05	0.000474	CcSEcCtD
Mianserin—Rash—Irinotecan—breast cancer	8.47e-05	0.000473	CcSEcCtD
Mianserin—Rash—Mitoxantrone—breast cancer	8.47e-05	0.000473	CcSEcCtD
Mianserin—Dermatitis—Mitoxantrone—breast cancer	8.46e-05	0.000473	CcSEcCtD
Mianserin—Dermatitis—Irinotecan—breast cancer	8.46e-05	0.000473	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Docetaxel—breast cancer	8.46e-05	0.000473	CcSEcCtD
Mianserin—Headache—Irinotecan—breast cancer	8.42e-05	0.00047	CcSEcCtD
Mianserin—Headache—Mitoxantrone—breast cancer	8.42e-05	0.00047	CcSEcCtD
Mianserin—Hypotension—Capecitabine—breast cancer	8.4e-05	0.000469	CcSEcCtD
Mianserin—Paraesthesia—Docetaxel—breast cancer	8.34e-05	0.000466	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—breast cancer	8.31e-05	0.000464	CcSEcCtD
Mianserin—Somnolence—Docetaxel—breast cancer	8.26e-05	0.000461	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—breast cancer	8.26e-05	0.000461	CcSEcCtD
Mianserin—Rash—Gemcitabine—breast cancer	8.25e-05	0.000461	CcSEcCtD
Mianserin—Dermatitis—Gemcitabine—breast cancer	8.24e-05	0.000461	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—breast cancer	8.24e-05	0.00046	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—breast cancer	8.22e-05	0.000459	CcSEcCtD
Mianserin—Headache—Gemcitabine—breast cancer	8.2e-05	0.000458	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Capecitabine—breast cancer	8.19e-05	0.000458	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—breast cancer	8.18e-05	0.000457	CcSEcCtD
Mianserin—Prochlorperazine—CYP3A4—breast cancer	8.17e-05	0.0332	CrCbGaD
Mianserin—Hepatitis—Doxorubicin—breast cancer	8.16e-05	0.000456	CcSEcCtD
Mianserin—Rash—Fluorouracil—breast cancer	8.11e-05	0.000453	CcSEcCtD
Mianserin—Dermatitis—Fluorouracil—breast cancer	8.11e-05	0.000453	CcSEcCtD
Mianserin—Paraesthesia—Capecitabine—breast cancer	8.07e-05	0.000451	CcSEcCtD
Mianserin—Headache—Fluorouracil—breast cancer	8.06e-05	0.00045	CcSEcCtD
Mianserin—Gastrointestinal disorder—Docetaxel—breast cancer	8.02e-05	0.000448	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—breast cancer	8.02e-05	0.000448	CcSEcCtD
Mianserin—Fatigue—Docetaxel—breast cancer	8.01e-05	0.000447	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—breast cancer	8e-05	0.000447	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—breast cancer	7.95e-05	0.000444	CcSEcCtD
Mianserin—Constipation—Docetaxel—breast cancer	7.94e-05	0.000444	CcSEcCtD
Mianserin—Asthenia—Paclitaxel—breast cancer	7.86e-05	0.000439	CcSEcCtD
Mianserin—Gastrointestinal disorder—Capecitabine—breast cancer	7.76e-05	0.000434	CcSEcCtD
Mianserin—Fatigue—Capecitabine—breast cancer	7.75e-05	0.000433	CcSEcCtD
Mianserin—Pruritus—Paclitaxel—breast cancer	7.75e-05	0.000433	CcSEcCtD
Mianserin—Mental disorder—Epirubicin—breast cancer	7.73e-05	0.000432	CcSEcCtD
Mianserin—Nortriptyline—CYP2D6—breast cancer	7.7e-05	0.0313	CrCbGaD
Mianserin—Constipation—Capecitabine—breast cancer	7.69e-05	0.00043	CcSEcCtD
Mianserin—Feeling abnormal—Docetaxel—breast cancer	7.65e-05	0.000428	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—breast cancer	7.62e-05	0.000426	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—breast cancer	7.61e-05	0.000425	CcSEcCtD
Mianserin—Anaemia—Methotrexate—breast cancer	7.58e-05	0.000424	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—breast cancer	7.57e-05	0.000423	CcSEcCtD
Mianserin—Feeling abnormal—Capecitabine—breast cancer	7.41e-05	0.000414	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—breast cancer	7.4e-05	0.000414	CcSEcCtD
Mianserin—Vertigo—Methotrexate—breast cancer	7.37e-05	0.000412	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—breast cancer	7.35e-05	0.000411	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—breast cancer	7.34e-05	0.00041	CcSEcCtD
Mianserin—Trimipramine—CYP2D6—breast cancer	7.25e-05	0.0295	CrCbGaD
Mianserin—Dizziness—Paclitaxel—breast cancer	7.25e-05	0.000405	CcSEcCtD
Mianserin—Mental disorder—Doxorubicin—breast cancer	7.15e-05	0.000399	CcSEcCtD
Mianserin—Convulsion—Methotrexate—breast cancer	7.11e-05	0.000397	CcSEcCtD
Mianserin—Anaemia—Epirubicin—breast cancer	7.09e-05	0.000396	CcSEcCtD
Mianserin—Agitation—Epirubicin—breast cancer	7.05e-05	0.000394	CcSEcCtD
Mianserin—Myalgia—Methotrexate—breast cancer	6.98e-05	0.00039	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—breast cancer	6.98e-05	0.00039	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.94e-05	0.000387	CcSEcCtD
Mianserin—Rash—Paclitaxel—breast cancer	6.91e-05	0.000386	CcSEcCtD
Mianserin—Dermatitis—Paclitaxel—breast cancer	6.9e-05	0.000386	CcSEcCtD
Mianserin—Vertigo—Epirubicin—breast cancer	6.9e-05	0.000385	CcSEcCtD
Mianserin—Syncope—Epirubicin—breast cancer	6.88e-05	0.000385	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—breast cancer	6.87e-05	0.000384	CcSEcCtD
Mianserin—Headache—Paclitaxel—breast cancer	6.86e-05	0.000384	CcSEcCtD
Mianserin—Confusional state—Methotrexate—breast cancer	6.75e-05	0.000377	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—breast cancer	6.75e-05	0.000377	CcSEcCtD
Mianserin—Asthenia—Docetaxel—breast cancer	6.66e-05	0.000372	CcSEcCtD
Mianserin—Convulsion—Epirubicin—breast cancer	6.65e-05	0.000372	CcSEcCtD
Mianserin—Hypertension—Epirubicin—breast cancer	6.63e-05	0.00037	CcSEcCtD
Mianserin—Nortriptyline—CYP3A4—breast cancer	6.61e-05	0.0269	CrCbGaD
Mianserin—Pruritus—Docetaxel—breast cancer	6.57e-05	0.000367	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—breast cancer	6.56e-05	0.000367	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—breast cancer	6.56e-05	0.000367	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—breast cancer	6.55e-05	0.000366	CcSEcCtD
Mianserin—Myalgia—Epirubicin—breast cancer	6.54e-05	0.000365	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—breast cancer	6.54e-05	0.000365	CcSEcCtD
Mianserin—Agitation—Doxorubicin—breast cancer	6.53e-05	0.000365	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—breast cancer	6.5e-05	0.000363	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.49e-05	0.000363	CcSEcCtD
Mianserin—Asthenia—Capecitabine—breast cancer	6.45e-05	0.00036	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—breast cancer	6.39e-05	0.000357	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—breast cancer	6.38e-05	0.000357	CcSEcCtD
Mianserin—Syncope—Doxorubicin—breast cancer	6.37e-05	0.000356	CcSEcCtD
Mianserin—Pruritus—Capecitabine—breast cancer	6.36e-05	0.000355	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—breast cancer	6.36e-05	0.000355	CcSEcCtD
Mianserin—Desipramine—CYP2D6—breast cancer	6.34e-05	0.0258	CrCbGaD
Mianserin—Confusional state—Epirubicin—breast cancer	6.32e-05	0.000353	CcSEcCtD
Mianserin—Oedema—Epirubicin—breast cancer	6.26e-05	0.00035	CcSEcCtD
Mianserin—Hypotension—Methotrexate—breast cancer	6.26e-05	0.000349	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—breast cancer	6.24e-05	0.000349	CcSEcCtD
Mianserin—Trimipramine—CYP3A4—breast cancer	6.22e-05	0.0253	CrCbGaD
Mianserin—Shock—Epirubicin—breast cancer	6.16e-05	0.000344	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—breast cancer	6.15e-05	0.000344	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—breast cancer	6.14e-05	0.000343	CcSEcCtD
Mianserin—Dizziness—Docetaxel—breast cancer	6.14e-05	0.000343	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—breast cancer	6.13e-05	0.000343	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—breast cancer	6.13e-05	0.000343	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—breast cancer	6.11e-05	0.000342	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—breast cancer	6.1e-05	0.000341	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—breast cancer	6.09e-05	0.00034	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—breast cancer	6.05e-05	0.000338	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—breast cancer	6.05e-05	0.000338	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—breast cancer	6.01e-05	0.000336	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.01e-05	0.000336	CcSEcCtD
Mianserin—Somnolence—Methotrexate—breast cancer	5.95e-05	0.000332	CcSEcCtD
Mianserin—Dizziness—Capecitabine—breast cancer	5.95e-05	0.000332	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—breast cancer	5.91e-05	0.00033	CcSEcCtD
Mianserin—Rash—Docetaxel—breast cancer	5.86e-05	0.000327	CcSEcCtD
Mianserin—Hypotension—Epirubicin—breast cancer	5.85e-05	0.000327	CcSEcCtD
Mianserin—Dermatitis—Docetaxel—breast cancer	5.85e-05	0.000327	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—breast cancer	5.84e-05	0.000327	CcSEcCtD
Mianserin—Headache—Docetaxel—breast cancer	5.82e-05	0.000325	CcSEcCtD
Mianserin—Oedema—Doxorubicin—breast cancer	5.8e-05	0.000324	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—breast cancer	5.78e-05	0.000323	CcSEcCtD
Mianserin—Fatigue—Methotrexate—breast cancer	5.77e-05	0.000322	CcSEcCtD
Mianserin—Nortriptyline—ALB—breast cancer	5.76e-05	0.0234	CrCbGaD
Mianserin—Musculoskeletal discomfort—Epirubicin—breast cancer	5.71e-05	0.000319	CcSEcCtD
Mianserin—Shock—Doxorubicin—breast cancer	5.7e-05	0.000319	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—breast cancer	5.68e-05	0.000318	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—breast cancer	5.68e-05	0.000317	CcSEcCtD
Mianserin—Rash—Capecitabine—breast cancer	5.67e-05	0.000317	CcSEcCtD
Mianserin—Dermatitis—Capecitabine—breast cancer	5.66e-05	0.000316	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—breast cancer	5.66e-05	0.000316	CcSEcCtD
Mianserin—Headache—Capecitabine—breast cancer	5.63e-05	0.000315	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—breast cancer	5.63e-05	0.000315	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—breast cancer	5.63e-05	0.000314	CcSEcCtD
Mianserin—Somnolence—Epirubicin—breast cancer	5.57e-05	0.000311	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—breast cancer	5.52e-05	0.000308	CcSEcCtD
Mianserin—Desipramine—CYP3A4—breast cancer	5.44e-05	0.0221	CrCbGaD
Mianserin—Hypotension—Doxorubicin—breast cancer	5.42e-05	0.000303	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—breast cancer	5.41e-05	0.000302	CcSEcCtD
Mianserin—Fatigue—Epirubicin—breast cancer	5.4e-05	0.000302	CcSEcCtD
Mianserin—Imipramine—CYP2D6—breast cancer	5.38e-05	0.0219	CrCbGaD
Mianserin—Constipation—Epirubicin—breast cancer	5.36e-05	0.000299	CcSEcCtD
Mianserin—Amitriptyline—CYP2D6—breast cancer	5.34e-05	0.0217	CrCbGaD
Mianserin—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.28e-05	0.000295	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—breast cancer	5.21e-05	0.000291	CcSEcCtD
Mianserin—Trimipramine—ABCB1—breast cancer	5.18e-05	0.0211	CrCbGaD
Mianserin—Feeling abnormal—Epirubicin—breast cancer	5.16e-05	0.000288	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—breast cancer	5.15e-05	0.000288	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—breast cancer	5e-05	0.00028	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—breast cancer	5e-05	0.000279	CcSEcCtD
Mianserin—Constipation—Doxorubicin—breast cancer	4.96e-05	0.000277	CcSEcCtD
Mianserin—Asthenia—Methotrexate—breast cancer	4.8e-05	0.000268	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—breast cancer	4.78e-05	0.000267	CcSEcCtD
Mianserin—Pruritus—Methotrexate—breast cancer	4.74e-05	0.000265	CcSEcCtD
Mianserin—Imipramine—CYP3A4—breast cancer	4.61e-05	0.0188	CrCbGaD
Mianserin—Amitriptyline—CYP3A4—breast cancer	4.58e-05	0.0186	CrCbGaD
Mianserin—Desipramine—ABCB1—breast cancer	4.53e-05	0.0184	CrCbGaD
Mianserin—Asthenia—Epirubicin—breast cancer	4.49e-05	0.000251	CcSEcCtD
Mianserin—Pruritus—Epirubicin—breast cancer	4.43e-05	0.000248	CcSEcCtD
Mianserin—Dizziness—Methotrexate—breast cancer	4.43e-05	0.000247	CcSEcCtD
Mianserin—Rash—Methotrexate—breast cancer	4.22e-05	0.000236	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—breast cancer	4.22e-05	0.000236	CcSEcCtD
Mianserin—Headache—Methotrexate—breast cancer	4.19e-05	0.000234	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—breast cancer	4.16e-05	0.000232	CcSEcCtD
Mianserin—Dizziness—Epirubicin—breast cancer	4.14e-05	0.000231	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—breast cancer	4.1e-05	0.000229	CcSEcCtD
Mianserin—Amitriptyline—ALB—breast cancer	4e-05	0.0163	CrCbGaD
Mianserin—Rash—Epirubicin—breast cancer	3.95e-05	0.000221	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—breast cancer	3.95e-05	0.00022	CcSEcCtD
Mianserin—Headache—Epirubicin—breast cancer	3.92e-05	0.000219	CcSEcCtD
Mianserin—Imipramine—ABCB1—breast cancer	3.84e-05	0.0156	CrCbGaD
Mianserin—Dizziness—Doxorubicin—breast cancer	3.83e-05	0.000214	CcSEcCtD
Mianserin—Amitriptyline—ABCB1—breast cancer	3.82e-05	0.0155	CrCbGaD
Mianserin—Rash—Doxorubicin—breast cancer	3.65e-05	0.000204	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—breast cancer	3.65e-05	0.000204	CcSEcCtD
Mianserin—Headache—Doxorubicin—breast cancer	3.63e-05	0.000203	CcSEcCtD
Mianserin—HRH1—Signaling by GPCR—HRAS—breast cancer	1.75e-06	1.39e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—breast cancer	1.75e-06	1.39e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—breast cancer	1.75e-06	1.38e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—breast cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—breast cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.74e-06	1.37e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.74e-06	1.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTEN—breast cancer	1.73e-06	1.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.73e-06	1.37e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.73e-06	1.37e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RELA—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SRC—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CG—breast cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SRC—breast cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—breast cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—breast cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—breast cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—breast cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—breast cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—breast cancer	1.69e-06	1.33e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCND1—breast cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—JUN—breast cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.66e-06	1.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.66e-06	1.31e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.65e-06	1.31e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SRC—breast cancer	1.65e-06	1.31e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCND1—breast cancer	1.65e-06	1.3e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HRAS—breast cancer	1.65e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—breast cancer	1.65e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—JUN—breast cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCND1—breast cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—JUN—breast cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—breast cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—breast cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HRAS—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTEN—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HRAS—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTEN—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HRAS—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ITPR1—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—breast cancer	1.6e-06	1.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.6e-06	1.26e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—breast cancer	1.6e-06	1.26e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTEN—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTEN—breast cancer	1.59e-06	1.25e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—breast cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.57e-06	1.24e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.57e-06	1.24e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—breast cancer	1.55e-06	1.22e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—breast cancer	1.55e-06	1.22e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCB1—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—breast cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.52e-06	1.2e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—breast cancer	1.52e-06	1.2e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.52e-06	1.2e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TYMS—breast cancer	1.52e-06	1.2e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NCOR1—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SRC—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CD—breast cancer	1.5e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—breast cancer	1.5e-06	1.18e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—JUN—breast cancer	1.5e-06	1.18e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—breast cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRAS—breast cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—breast cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—breast cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SRC—breast cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SRC—breast cancer	1.47e-06	1.16e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—breast cancer	1.45e-06	1.15e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.45e-06	1.15e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—breast cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CG—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A1—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—breast cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—breast cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ERCC2—breast cancer	1.41e-06	1.11e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—breast cancer	1.41e-06	1.11e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK3—breast cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRAS—breast cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.37e-06	1.08e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.36e-06	1.07e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK3—breast cancer	1.36e-06	1.07e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.35e-06	1.06e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—breast cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SRC—breast cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—breast cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—breast cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—breast cancer	1.31e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.31e-06	1.03e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CB—breast cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—breast cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CD—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.26e-06	9.94e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—breast cancer	1.26e-06	9.93e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—breast cancer	1.25e-06	9.9e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—breast cancer	1.25e-06	9.88e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.24e-06	9.84e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—breast cancer	1.24e-06	9.81e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.24e-06	9.77e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—breast cancer	1.23e-06	9.71e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—breast cancer	1.22e-06	9.66e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—breast cancer	1.22e-06	9.66e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—breast cancer	1.22e-06	9.65e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—breast cancer	1.22e-06	9.63e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—breast cancer	1.22e-06	9.62e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—breast cancer	1.22e-06	9.61e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—breast cancer	1.2e-06	9.51e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRAS—breast cancer	1.2e-06	9.5e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.2e-06	9.48e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—breast cancer	1.2e-06	9.47e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRAS—breast cancer	1.2e-06	9.45e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—breast cancer	1.19e-06	9.42e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.18e-06	9.3e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.16e-06	9.19e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—breast cancer	1.15e-06	9.09e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—breast cancer	1.14e-06	9.05e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—breast cancer	1.14e-06	9.05e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.14e-06	9.02e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTEN—breast cancer	1.13e-06	8.91e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.12e-06	8.87e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.12e-06	8.85e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CG—breast cancer	1.11e-06	8.8e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—breast cancer	1.11e-06	8.8e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.11e-06	8.78e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CB—breast cancer	1.11e-06	8.74e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—breast cancer	1.1e-06	8.72e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.1e-06	8.69e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—breast cancer	1.1e-06	8.66e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—breast cancer	1.09e-06	8.58e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—breast cancer	1.08e-06	8.56e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—breast cancer	1.06e-06	8.39e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—breast cancer	1.06e-06	8.35e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRAS—breast cancer	1.05e-06	8.34e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRAS—breast cancer	1.04e-06	8.21e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRAS—breast cancer	1.04e-06	8.19e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.03e-06	8.12e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	8.07e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—breast cancer	1.01e-06	7.98e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—breast cancer	9.97e-07	7.88e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—breast cancer	9.93e-07	7.86e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—breast cancer	9.91e-07	7.84e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—breast cancer	9.87e-07	7.81e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CD—breast cancer	9.79e-07	7.74e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—breast cancer	9.66e-07	7.64e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTEN—breast cancer	9.55e-07	7.55e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRAS—breast cancer	9.44e-07	7.47e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—breast cancer	9.35e-07	7.39e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—breast cancer	9.31e-07	7.36e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—breast cancer	9.24e-07	7.31e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—breast cancer	9.16e-07	7.25e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—breast cancer	9.14e-07	7.23e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—breast cancer	9.04e-07	7.15e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CB—breast cancer	8.53e-07	6.75e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—breast cancer	8.45e-07	6.68e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—breast cancer	8.34e-07	6.59e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—breast cancer	7.95e-07	6.29e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTEN—breast cancer	7.37e-07	5.83e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—breast cancer	6.74e-07	5.33e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—breast cancer	6.5e-07	5.14e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—breast cancer	5.5e-07	4.35e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—breast cancer	5.2e-07	4.11e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—breast cancer	4.25e-07	3.36e-06	CbGpPWpGaD
